תוצאות חיפוש - Learoyd, Maria
- Showing 1 - 5 results of 5
-
1
-
2
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in... מאת Leijen, Suzanne, Soetekouw, Patricia M. M. B., Jeffry Evans, T. R., Nicolson, Marianne, Schellens, Jan H. M., Learoyd, Maria, Grinsted, Lynda, Zazulina, Victoria, Pwint, Thinn, Middleton, Mark
יצא לאור 2011Text -
3
Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma מאת O'Neil, Bert H., Goff, Laura W., Kauh, John Sae Wook, Strosberg, Jonathan R., Bekaii-Saab, Tanios S., Lee, Ruey-min, Kazi, Aslamuzzaman, Moore, Dominic T., Learoyd, Maria, Lush, Richard M., Sebti, Said M., Sullivan, Daniel M.
יצא לאור 2011Text -
4
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment מאת Rolfo, Christian, Isambert, Nicolas, Italiano, Antoine, Molife, L. Rhoda, Schellens, Jan H.M., Blay, Jean‐Yves, Decaens, Thomas, Kristeleit, Rebecca, Rosmorduc, Olivier, Demlova, Regina, Lee, Myung‐Ah, Ravaud, Alain, Kopeckova, Katerina, Learoyd, Maria, Bannister, Wendy, Locker, Gershon, de Vos‐Geelen, Judith
יצא לאור 2020Text -
5
Anti-tumour activity in RAS-driven tumours by blocking AKT and MEK מאת Tolcher, Anthony W., Khan, Khurum, Ong, Michael, Banerji, Udai, Papadimitrakopoulou, Vassiliki, Gandara, David R., Patnaik, Amita, Baird, Richard D., Olmos, David, Garrett, Christopher R., Skolnik, Jeffrey M., Rubin, Eric H., Smith, Paul D., Huang, Pearl, Learoyd, Maria, Shannon, Keith A., Morosky, Anne, Tetteh, Ernestina, Jou, Ying-Ming, Papadopoulos, Kyriakos P., Moreno, Victor, Kaiser, Brianne, Yap, Timothy A., Yan, Li, de Bono, Johann S.
יצא לאור 2014Text